Aging, the metabolic syndrome, and ischemic stroke: Redefining the approach for studying the blood-brain barrier in a complex neurological disease

Advances in Pharmacology

Volumn 71, Issue , 2014, Pages 411-449

  Lucke Wold, Brandon P ^a   Logsdon, Aric F ^a,b   Turner, Ryan C ^a   Rosen, Charles L ^a   Huber, Jason D ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Comorbidity; Diabetes; Hypertension; Middle cerebral artery occlusion; Neurovascular unit

Indexed keywords

3 NITROTYROSINE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM ION; CATALASE; CLAUDIN 5; COLLAGEN; CYTOCHROME C; CYTOKINE; ENDONUCLEASE; FREE RADICAL; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID; GLUTAMIC ACID; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OCCLUDIN; PHOSPHOLIPASE; PROTEIN ZO1; REACTIVE OXYGEN METABOLITE; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AGING; ALZHEIMER DISEASE; ANTICOAGULANT THERAPY; APOPTOSIS; ARTICLE; ASTROCYTE; ATHEROSCLEROSIS; BLOOD BRAIN BARRIER; BODY MASS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CELL AGING; CELL DIFFERENTIATION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CYTOKINE RELEASE; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; EXCITOTOXICITY; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LONG TERM POTENTIATION; METABOLIC SYNDROME X; MICROGLIA; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERICYTE; PERIPHERAL NEUROPATHY; SECONDARY PREVENTION; SOCIAL STATUS; ANIMAL; BRAIN; CYTOLOGY; METABOLISM; PHYSIOLOGY; STROKE;

AGING; ANIMALS; BRAIN; CELL AGING; HUMANS; METABOLIC SYNDROME X; STROKE;

EID: 84907979170     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/bs.apha.2014.07.001     Document Type: Chapter

References (211)

1. Abd El Mohsen M.M., Iravani M.M., Spencer J.P., Rose S., Fahim A.T., Motawi T.M., et al. Age-associated changes in protein oxidation and proteasome activities in rat brain: Modulation by antioxidants. Biochemical and Biophysical Research Communications 2005, 336(2):386-391. 10.1016/j.bbrc.2005.07.201.
2. Ahrens L., Shoeib M., Harner T., Lane D.A., Guo R., Reiner E.J. Comparison of annular diffusion denuder and high volume air samplers for measuring per- and polyfluoroalkyl substances in the atmosphere. Analytical Chemistry 2011, 83(24):9622-9628. 10.1021/ac202414w.
3. Alhusban A., Fagan S.C. Secondary prevention of stroke in the elderly: A review of the evidence. The American Journal of Geriatric Pharmacotherapy 2011, 9(3):143-152. 10.1016/j.amjopharm.2011.04.002.
4. Amanzada A., Malik I.A., Blaschke M., Khan S., Rahman H., Ramadori G., et al. Identification of CD68(+) neutrophil granulocytes in in vitro model of acute inflammation and inflammatory bowel disease. International Journal of Clinical and Experimental Pathology 2013, 6(4):561-570.
5. Artola A. Diabetes-, stress- and ageing-related changes in synaptic plasticity in hippocampus and neocortex-The same metaplastic process?. European Journal of Pharmacology 2008, 585(1):153-162. 10.1016/j.ejphar.2007.11.084.
6. Auriel E., Gur A.Y., Uralev O., Brill S., Shopin L., Karni A., et al. Characteristics of first ever ischemic stroke in the very elderly: Profile of vascular risk factors and clinical outcome. Clinical Neurology and Neurosurgery 2011, 113(8):654-657. 10.1016/j.clineuro.2011.05.011.
7. Badan I., Buchhold B., Hamm A., Gratz M., Walker L.C., Platt D., et al. Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery. Journal of Cerebral Blood Flow and Metabolism 2003, 23(7):845-854. 10.1097/01.WCB.0000071883.63724.A7.
8. Bailey-Downs L.C., Tucsek Z., Toth P., Sosnowska D., Gautam T., Sonntag W.E., et al. Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: A paracrine mechanism contributing to vascular redox dysregulation and inflammation. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2013, 68(7):780-792. Epub 2012 Dec 3. 10.1093/gerona/gls238.
9. Bakirci S., Kafa I.M., Uysal M., Ayberk Kurt M. Increased adult neurogenesis in the subventricular zone in a rat model of sepsis. Neuroscience Letters 2011, 497(1):27-31. 10.1016/j.neulet.2011.04.014.
10. Bartels A.L., Kortekaas R., Bart J., Willemsen A.T., de Klerk O.L., de Vries J.J., et al. Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration. Neurobiology of Aging 2009, 30(11):1818-1824. 10.1016/j.neurobiolaging.2008.02.002.
11. Bartlett D.B., Firth C.M., Phillips A.C., Moss P., Baylis D., Syddall H., et al. The age-related increase in low-grade systemic inflammation (inflamm-aging) is not driven by cytomegalovirus infection. Aging Cell 2012, 11(5):912-915. 10.1111/j.1474-9726.2012.00849.x.
12. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiological Reviews 2007, 87(1):245-313. 87/1/245 [pii]. 10.1152/physrev.00044.2005.
13. Bhat R., Crowe E.P., Bitto A., Moh M., Katsetos C.D., Garcia F.U., et al. Astrocyte senescence as a component of Alzheimer's disease. PLoS One 2012, 7(9):e45069. 10.1371/journal.pone.0045069.
14. Biessels G.J., van der Heide L.P., Kamal A., Bleys R.L., Gispen W.H. Ageing and diabetes: Implications for brain function. European Journal of Pharmacology 2002, 441(1-2):1-14.
15. Bilbo S.D. How cytokines leave their mark: The role of the placenta in developmental programming of brain and behavior. Brain, Behavior, and Immunity 2011, 25(4):602-603. 10.1016/j.bbi.2011.01.018.
16. Bitto A., Sell C., Crowe E., Lorenzini A., Malaguti M., Hrelia S., et al. Stress-induced senescence in human and rodent astrocytes. Experimental Cell Research 2010, 316(17):2961-2968. 10.1016/j.yexcr.2010.06.021.
17. Blasko I., Stampfer-Kountchev M., Robatscher P., Veerhuis R., Eikelenboom P., Grubeck-Loebenstein B. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: The role of microglia and astrocytes. Aging Cell 2004, 3(4):169-176. 10.1111/j.1474-9728.2004.00101.x.
18. Boden-Albala B., Sacco R.L., Lee H.S., Grahame-Clarke C., Rundek T., Elkind M.V., et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan study. Stroke 2008, 39(1):30-35. STROKEAHA.107.496588 [pii]. 10.1161/STROKEAHA.107.496588.
19. Borghini A., Cervelli T., Galli A., Andreassi M.G. DNA modifications in atherosclerosis: From the past to the future. Atherosclerosis 2013, 230(2):202-209. 10.1016/j.atherosclerosis.2013.07.038.
20. Brandt M.D., Storch A. Neurogenesis in the adult brain: From bench to bedside?. Fortschritte der Neurologie-Psychiatrie 2008, 76(9):517-529. 10.1055/s-2008-1038218.
21. Brera B., Serrano A., de Ceballos M.L. Beta-amyloid peptides are cytotoxic to astrocytes in culture: A role for oxidative stress. Neurobiology of Disease 2000, 7(4):395-405. 10.1006/nbdi.2000.0313.
22. Brown M.K., Naidoo N. The endoplasmic reticulum stress response in aging and age-related diseases. Frontiers in Physiology 2012, 3:263. 10.3389/fphys.2012.00263.
23. Buschini E., Piras A., Nuzzi R., Vercelli A. Age related macular degeneration and drusen: Neuroinflammation in the retina. Progress in Neurobiology 2011, 95(1):14-25. 10.1016/j.pneurobio.2011.05.011.
24. Cai D. Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends in Endocrinology and Metabolism 2013, 24(1):40-47. S1043-2760(12)00203-2 [pii]. 10.1016/j.tem.2012.11.003.
25. Cai Z., Yan Y., Wang Y. Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder. Clinical Interventions in Aging 2013, 8:1089-1095. cia-8-1089 [pii]. 10.2147/CIA.S46536.
26. Calling S., Ji J., Sundquist J., Sundquist K., Zoller B. Shared and non-shared familial susceptibility of coronary heart disease, ischemic stroke, peripheral artery disease and aortic disease. International Journal of Cardiology 2013, 168(3):2844-2850. 10.1016/j.ijcard.2013.03.149.
27. Campuzano O., Castillo-Ruiz M.M., Acarin L., Gonzalez B., Castellano B. Decreased myeloperoxidase expressing cells in the aged rat brain after excitotoxic damage. Experimental Gerontology 2011, 46(9):723-730. 10.1016/j.exger.2011.05.003.
28. Cardona F., Tunez I., Tasset I., Montilla P., Collantes E., Tinahones F.J. Fat overload aggravates oxidative stress in patients with the metabolic syndrome. European Journal of Clinical Investigation 2008, 38(7):510-515. ECI1959 [pii]. 10.1111/j.1365-2362.2008.01959.x.
29. Castilla-Guerra L., Fernandez-Moreno Mdel C., Alvarez-Suero J. Secondary stroke prevention in the elderly: New evidence in hypertension and hyperlipidemia. European Journal of Internal Medicine 2009, 20(6):586-590. 10.1016/j.ejim.2009.06.005.
30. Cavuoto L.A., Nussbaum M.A. The influences of obesity and age on functional performance during intermittent upper extremity tasks. Journal of Occupational and Environmental Hygiene 2014, 10.1080/15459624.2014.887848.
31. Cerbai F., Lana D., Nosi D., Petkova-Kirova P., Zecchi S., Brothers H.M., et al. The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus. PLoS One 2012, 7(9):e45250. 10.1371/journal.pone.0045250.
32. Cernak I., Chang T., Ahmed F.A., Cruz M.I., Vink R., Stoica B., et al. Pathophysiological response to experimental diffuse brain trauma differs as a function of developmental age. Developmental Neuroscience 2010, 32(5-6):442-453. 10.1159/000320085.
33. Ciccarelli R., Di Iorio P., Bruno V., Battaglia G., D'Alimonte I., D'Onofrio M., et al. Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes. Glia 1999, 27(3):275-281.
34. Ciesielska A., Joniec I., Kurkowska-Jastrzebska I., Cudna A., Przybylkowski A., Czlonkowska A., et al. The impact of age and gender on the striatal astrocytes activation in murine model of Parkinson's disease. Inflammation Research 2009, 58(11):747-753. 10.1007/s00011-009-0026-6.
35. Clarner T., Diederichs F., Berger K., Denecke B., Gan L., van der Valk P., et al. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions. Glia 2012, 60(10):1468-1480. 10.1002/glia.22367.
36. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nature Reviews. Neuroscience 2001, 2(11):806-819. 35097565 [pii]. 10.1038/35097565.
37. Cohen L., Curhan G.C., Forman J.P. Influence of age on the association between lifestyle factors and risk of hypertension. Journal of the American Society of Hypertension 2012, 6(4):284-290. 10.1016/j.jash.2012.06.002.
38. Cookson M.R. The biochemistry of Parkinson's disease. Annual Review of Biochemistry 2005, 74:29-52. 10.1146/annurev.biochem.74.082803.133400.
39. Costopoulos C., Liew T.V., Bennett M. Ageing and atherosclerosis: Mechanisms and therapeutic options. Biochemical Pharmacology 2008, 75(6):1251-1261. 10.1016/j.bcp.2007.10.006.
40. Cotrina M.L., Nedergaard M. Astrocytes in the aging brain. Journal of Neuroscience Research 2002, 67(1):1-10.
41. Del Brutto O.H., Montalvan M., Tettamanti D., Penaherrera E., Santibanez R., Pow-Chon-Long F., et al. The "know your numbers" program in Atahualpa-a pilot study aimed to reduce cardiovascular diseases and stroke burden in rural communities of developing countries. International Journal of Cardiology 2013, 168(3):3123-3124. 10.1016/j.ijcard.2013.04.049.
42. Del Brutto O.H., Zambrano M., Penaherrera E., Montalvan M., Pow-Chon-Long F., Tettamanti D. Prevalence of the metabolic syndrome and its correlation with the cardiovascular health status in stroke- and ischemic heart disease-free Ecuadorian natives/mestizos aged >/=40 years living in Atahualpa: A population-based study. Diabetes & Metabolic Syndrome 2013, 7(4):218-222. 10.1016/j.dsx.2013.10.006.
43. Denti L., Artoni A., Scoditti U., Caminiti C., Giambanco F., Casella M., et al. Impact of gender-age interaction on the outcome of ischemic stroke in an Italian cohort of patients treated according to a standardized clinical pathway. European Journal of Internal Medicine 2013, 24(8):807-812. 10.1016/j.ejim.2013.07.015.
44. Devaraj S., Goyal R., Jialal I. Inflammation, oxidative stress, and the metabolic syndrome. US Endocrinology 2008, 4(2):32-37.
45. Dharmasaroja P.A., Muengtaweepongsa S., Dharmasaroja P. Intravenous thrombolysis in Thai patients with acute ischemic stroke: Role of aging. Journal of Stroke and Cerebrovascular Diseases 2013, 22(3):227-231. 10.1016/j.jstrokecerebrovasdis.2011.08.001.
46. Di Luca M., Ruts L., Gardoni F., Cattabeni F., Biessels G.J., Gispen W.H. NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats. Diabetologia 1999, 42(6):693-701. 10.1007/s001250051217.
47. Dinapoli V.A., Benkovic S.A., Li X., Kelly K.A., Miller D.B., Rosen C.L., et al. Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat. Neuroscience 2010, 170(2):633-644. 10.1016/j.neuroscience.2010.07.011.
48. Dinapoli V.A., Rosen C.L., Nagamine T., Crocco T. Selective MCA occlusion: A precise embolic stroke model. Journal of Neuroscience Methods 2006, 154(1-2):233-238. S0165-0270(06)00007-0 [pii]. 10.1016/j.jneumeth.2005.12.026.
49. Dixon-Ibarra A., Horner-Johnson W. Disability status as an antecedent to chronic conditions: National health interview survey, 2006-2012. Preventing Chronic Disease 2014, 11:E15. 10.5888/pcd11.130251.
50. Droste D.W., Keipes M. The reduction of stroke risk, risk of myocardial infarction and death by healthy diet and physical activity. Bulletin de la Société des Sciences Médicales du Grand-Duché de Luxembourg 2013, 2:51-62.
51. Easton A.S. Neutrophils and stroke-Can neutrophils mitigate disease in the central nervous system?. International Immunopharmacology 2013, 17(4):1218-1225. 10.1016/j.intimp.2013.06.015.
52. Endres T., Lessmann V. Age-dependent deficits in fear learning in heterozygous BDNF knock-out mice. Learning & Memory 2012, 19(12):561-570. 10.1101/lm.028068.112.
53. Fedoroff S., White R., Neal J., Subrahmanyan L., Kalnins V.I. Astrocyte cell lineage. II. Mouse fibrous astrocytes and reactive astrocytes in cultures have vimentin- and GFP-containing intermediate filaments. Brain Research 1983, 283(2-3):303-315.
54. Feldstein C.A. Early treatment of hypertension in acute ischemic and intracerebral hemorrhagic stroke: Progress achieved, challenges, and perspectives. Journal of the American Society of Hypertension 2013, 10.1016/j.jash.2013.09.004.
55. Ferron S.R., Marques-Torrejon M.A., Mira H., Flores I., Taylor K., Blasco M.A., et al. Telomere shortening in neural stem cells disrupts neuronal differentiation and neuritogenesis. The Journal of Neuroscience 2009, 29(46):14394-14407. 10.1523/JNEUROSCI.3836-09.2009.
56. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408(6809):239-247. 10.1038/35041687.
57. Fisher M., Loewy R., Hardy K., Schlosser D., Vinogradov S. Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia. Annual Review of Clinical Psychology 2013, 9:435-463. 10.1146/annurev-clinpsy-032511-143134.
58. Floyd R.A., Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiology of Aging 2002, 23(5):795-807. S0197458002000192 [pii].
59. Folsom A.R., Yatsuya H., Nettleton J.A., Lutsey P.L., Cushman M., Rosamond W.D., et al. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. Journal of the American College of Cardiology 2011, 57(16):1690-1696. 10.1016/j.jacc.2010.11.041.
60. Fonseca A.C., Geraldes R., Almeida V., Pinhoe Melo T. Treatment with rtPA of stroke associated with intravenous immunoglobulins perfusion. Journal of Neurological Science 2011, 308(1-2):180-181. 10.1016/j.jns.2011.05.037.
61. Fortuno A., San Jose G., Moreno M.U., Beloqui O., Diez J., Zalba G. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes 2006, 55(1):209-215. 55/1/209 [pii].
62. Franceschi C. Inflamm-aging as a major characteristic of old people: Can it be prevented or cured?. Nutrition Reviews 2007, 65(12 Pt. 2):S173-S176.
63. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., et al. Inflamm-aging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mechanisms of Ageing and Development 2007, 128(1):92-105. 10.1016/j.mad.2006.11.016.
64. Gargalovic P.S., Gharavi N.M., Clark M.J., Pagnon J., Yang W.P., He A., et al. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26(11):2490-2496. 01.ATV.0000242903.41158.a1 [pii]. 10.1161/01.ATV.0000242903.41158.a1.
65. Ghezzi A.C., Cambri L.T., Botezelli J.D., Ribeiro C., Dalia R.A., de Mello M.A. Metabolic syndrome markers in wistar rats of different ages. Diabetology & Metabolic Syndrome 2012, 4(1):16. 10.1186/1758-5996-4-16.
66. Giantin V., Semplicini A., Franchin A., Simonato M., Baccaglini K., Attanasio F., et al. Outcome after acute ischemic stroke (AIS) in older patients: Effects of age, neurological deficit severity and blood pressure (BP) variations. Archives of Gerontology and Geriatrics 2011, 52(3):e185-e191. 10.1016/j.archger.2010.11.002.
67. Gibson S.C., Le Page P.A., Taylor C.J. Laparoscopic sleeve gastrectomy: Review of 500 cases in single surgeon Australian practice. ANZ Journal of Surgery 2013, 10.1111/ans.12483.
68. Glogowska-Ligus J., Dabek J., Zych-Twardowska E., Tkacz M. Expression analysis of intercellular adhesion molecule-2 (ICAM-2) in the context of classical cardiovascular risk factors in acute coronary syndrome patients. Archives of Medical Science 2013, 9(6):1035-1039. 10.5114/aoms.2012.28808.
69. Golden S.H., Hill-Briggs F., Williams K., Stolka K., Mayer R.S. Management of diabetes during acute stroke and inpatient stroke rehabilitation. Archives of Physical Medicine and Rehabilitation 2005, 86(12):2377-2384. 10.1016/j.apmr.2005.07.306.
70. Gomes V.A., Casella-Filho A., Chagas A.C., Tanus-Santos J.E. Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome. Nitric Oxide 2008, 19(4):345-350. S1089-8603(08)00365-0 [pii]. 10.1016/j.niox.2008.08.005.
71. Graham J.E., Ripsin C.M., Deutsch A., Kuo Y.F., Markello S., Granger C.V., et al. Relationship between diabetes codes that affect medicare reimbursement (tier comorbidities) and outcomes in stroke rehabilitation. Archives of Physical Medicine and Rehabilitation 2009, 90(7):1110-1116. 10.1016/j.apmr.2009.01.014.
72. Guyton K.Z., Gorospe M., Wang X., Mock Y.D., Kokkonen G.C., Liu Y., et al. Age-related changes in activation of mitogen-activated protein kinase cascades by oxidative stress. The Journal of Investigative Dermatology 1998, 3(1):23-27.
73. Guyton K.Z., Liu Y., Gorospe M., Xu Q., Holbrook N.J. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. The Journal of Biological Chemistry 1996, 271(8):4138-4142.
74. Haast R.A., Kiliaan A.J. Impact of fatty acids on brain circulation, structure and function. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2014, 10.1016/j.plefa.2014.01.002.
75. Hawkes C.A., Michalski D., Anders R., Nissel S., Grosche J., Bechmann I., et al. Stroke-induced opposite and age-dependent changes of vessel-associated markers in co-morbid transgenic mice with Alzheimer-like alterations. Experimental Neurology 2013, 250:270-281. 10.1016/j.expneurol.2013.09.020.
76. Hayashi Y., Nakanishi H. Microglia and synaptic reorganization: Focus on the movement and functions of microglial processes. Nihon Yakurigaku Zasshi 2013, 142(5):231-235.
77. Hefendehl J.K., Neher J.J., Suhs R.B., Kohsaka S., Skodras A., Jucker M. Homeostatic and injury-induced microglia behavior in the aging brain. Aging Cell 2014, 13(1):60-69. 10.1111/acel.12149.
78. Heiss C., Keymel S., Niesler U., Ziemann J., Kelm M., Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. Journal of the American College of Cardiology 2005, 45(9):1441-1448. 10.1016/j.jacc.2004.12.074.
79. Hildrum B., Mykletun A., Hole T., Midthjell K., Dahl A.A. Age-specific prevalence of the metabolic syndrome defined by the international diabetes federation and the national cholesterol education program: The Norwegian HUNT 2 study. BMC Public Health 2007, 7:220. 1471-2458-7-220 [pii]. 10.1186/1471-2458-7-220.
80. Hisham N.F., Bayraktutan U. Epidemiology, pathophysiology, and treatment of hypertension in ischaemic stroke patients. Journal of Stroke and Cerebrovascular Diseases 2013, 22(7):e4-e14. 10.1016/j.jstrokecerebrovasdis.2012.05.001.
81. Hodge A.M., Flicker L., O'Dea K., English D.R., Giles G.G. Diabetes and ageing in the Melbourne collaborative cohort study (MCCS). Diabetes Research and Clinical Practice 2013, 100(3):398-403. 10.1016/j.diabres.2013.03.024.
82. Hof P.R., Duan H., Page T.L., Einstein M., Wicinski B., He Y., et al. Age-related changes in GluR2 and NMDAR1 glutamate receptor subunit protein immunoreactivity in corticocortically projecting neurons in macaque and patas monkeys. Brain Research 2002, 928(1-2):175-186. S0006899301033455 [pii].
83. Holash J.A., Noden D.M., Stewart P.A. Re-evaluating the role of astrocytes in blood-brain barrier induction. Developmental Dynamics 1993, 197(1):14-25. 10.1002/aja.1001970103.
84. Holden C.A., Collins V.R., Handelsman D.J., Jolley D., Pitts M. Healthy aging in a cross-sectional study of Australian men: What has sex got to do with it?. The Aging Male 2014, Men in Australia Telephone Survey Working, Group. 10.3109/13685538.2013.843167.
85. Hopp S.C., Royer S., Brothers H.M., Kaercher R.M., D'Angelo H., Bardou I., et al. Age-associated alterations in the time-dependent profile of pro- and anti-inflammatory proteins within the hippocampus in response to acute exposure to interleukin-1beta. Journal of Neuroimmunology 2014, 267(1-2):86-91. 10.1016/j.jneuroim.2013.12.010.
86. Hossmann K.A. Pathophysiology and therapy of experimental stroke. Cellular and Molecular Neurobiology 2006, 26(7-8):1057-1083. 10.1007/s10571-006-9008-1.
87. Hossmann K.A. Pathophysiological basis of translational stroke research. Folia Neuropathologica 2009, 47(3):213-227. 13176 [pii].
88. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140(6):900-917. S0092-8674(10)00187-X [pii]. 10.1016/j.cell.2010.02.034.
89. Howard V.J., Woolson R.F., Egan B.M., Nicholas J.S., Adams R.J., Howard G., et al. Prevalence of hypertension by duration and age at exposure to the stroke belt. Journal of the American Society of Hypertension 2010, 4(1):32-41. 10.1016/j.jash.2010.02.001.
90. Hui X., Matsushita K., Sang Y., Ballew S.H., Fulop T., Coresh J. CKD and cardiovascular disease in the atherosclerosis risk in communities (ARIC) study: Interactions with age, sex, and race. American Journal of Kidney Diseases 2013, 62(4):691-702. 10.1053/j.ajkd.2013.04.010.
91. Huizinga R., van der Star B.J., Kipp M., Jong R., Gerritsen W., Clarner T., et al. Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis. Glia 2012, 60(3):422-431. 10.1002/glia.22276.
92. Joseph J., Koka M., Aronow W.S. Prevalence of moderate and severe renal insufficiency in older persons with hypertension, diabetes mellitus, coronary artery disease, peripheral arterial disease, ischemic stroke, or congestive heart failure in an academic nursing home. Journal of the American Medical Directors Association 2008, 9(4):257-259. 10.1016/j.jamda.2008.01.002.
93. Kaffashian S., Dugravot A., Brunner E.J., Sabia S., Ankri J., Kivimaki M., et al. Midlife stroke risk and cognitive decline: A 10-year follow-up of the Whitehall II cohort study. Alzheimers Dement 2013, 9(5):572-579. 10.1016/j.jalz.2012.07.001.
94. Kastorini C.M., Georgousopoulou E., Vemmos K.N., Nikolaou V., Kantas D., Milionis H.J., et al. Comparative analysis of cardiovascular disease risk factors influencing nonfatal acute coronary syndrome and ischemic stroke. The American Journal of Cardiology 2013, 112(3):349-354. 10.1016/j.amjcard.2013.03.039.
95. Kim O.J., Hong S.H., Jeon Y.J., Oh S.H., Kim H.S., Park Y.S., et al. Gene-environment interactions between methylenetetrahydrofolate reductase (MTHFR) 677C>T and metabolic syndrome for the prevalence of ischemic stroke in Koreans. Neuroscience Letters 2013, 533:11-16. 10.1016/j.neulet.2012.11.031.
96. Kim M.S., Kim D.S., Kim H.S., Kang S.W., Kang Y.H. Inhibitory effects of luteolin on transendothelial migration of monocytes and formation of lipid-laden macrophages. Nutrition 2012, 28(10):1044-1054. 10.1016/j.nut.2011.12.003.
97. Kishida K., Funahashi T., Shimomura I. Adiponectin as a routine clinical biomarker. Best Practice & Research. Clinical Endocrinology & Metabolism 2014, 28(1):119-130. 10.1016/j.beem.2013.08.006.
98. Kral M., Sanak D., Veverka T., Hutyra M., Vindis D., Kuncarova A., et al. Troponin T in acute ischemic stroke. The American Journal of Cardiology 2013, 112(1):117-121. 10.1016/j.amjcard.2013.02.067.
99. Kristian T., Siesjo B.K. Calcium in ischemic cell death. Stroke 1998, 29(3):705-718.
100. Krouwer V.J., Hekking L.H., Langelaar-Makkinje M., Regan-Klapisz E., Post J.A. Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability. Vascular Cell 2012, 4(1):12. 10.1186/2045-824X-4-12.
101. Kurl S., Laukkanen J.A., Niskanen L., Laaksonen D., Sivenius J., Nyyssonen K., et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006, 37(3):806-811. 01.STR.0000204354.06965.44 [pii]. 10.1161/01.STR.0000204354.06965.44.
102. Lakatta E.G. Central arterial aging and the epidemic of systolic hypertension and atherosclerosis. Journal of the American Society of Hypertension 2007, 1(5):302-340. 10.1016/j.jash.2007.05.001.
103. Laloux P., Ossemann M., Jamart J. Family history of hypertension is not an independent genetic factor predisposing to ischemic stroke subtypes. Clinical Neurology and Neurosurgery 2007, 109(3):247-249. 10.1016/j.clineuro.2006.09.005.
104. Le R., Esquenazi S. Astrocytes mediate cerebral cortical neuronal axon and dendrite growth, in part, by release of fibroblast growth factor. Neurological Research 2002, 24(1):81-92. 10.1179/016164102101199459.
105. Lee S.W., Clemenson G.D., Gage F.H. New neurons in an aged brain. Behavioural Brain Research 2012, 227(2):497-507. 10.1016/j.bbr.2011.10.009.
106. Lee J., Duan W., Long J.M., Ingram D.K., Mattson M.P. Dietary restriction increases the number of newly generated neural cells, and induces BDNF expression, in the dentate gyrus of rats. Journal of Molecular Neuroscience 2000, 15(2):99-108. 10.1385/JMN:15:2:99.
107. Lee J.T., Liu H.L., Yang J.T., Yang S.T., Lin J.R., Lee T.H. Longitudinal MR imaging study in the prediction of ischemic susceptibility after cerebral hypoperfusion in rats: Influence of aging and hypertension. Neuroscience 2014, 257:31-40. 10.1016/j.neuroscience.2013.10.066.
108. Li J.F., Lai D.D., Lin Z.H., Jiang T.Y., Zhang A.M., Dai J.F. Comparison of the long-term results of roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: A systematic review and meta-analysis of randomized and nonrandomized trials. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2014, 24(1):1-11. 10.1097/SLE.0000000000000041.
109. Lian X.Y., Stringer J.L. Astrocytes contribute to regulation of extracellular calcium and potassium in the rat cerebral cortex during spreading depression. Brain Research 2004, 1012(1-2):177-184. 10.1016/j.brainres.2004.04.011.
110. Liddell J.R., Robinson S.R., Dringen R., Bishop G.M. Astrocytes retain their antioxidant capacity into advanced old age. Glia 2010, 58(12):1500-1509. 10.1002/glia.21024.
111. Lim S., Choi H.J., Shin H., Khang A.R., Kang S.M., Yoon J.W., et al. Subclinical atherosclerosis in a community-based elderly cohort: The Korean longitudinal study on health and aging. International Journal of Cardiology 2012, 155(1):126-133. 10.1016/j.ijcard.2011.05.054.
112. Lima A., Sardinha V.M., Oliveira A.F., Reis M., Mota C., Silva M.A., et al. Astrocyte pathology in the prefrontal cortex impairs the cognitive function of rats. Molecular Psychiatry 2014, 1. 10.1038/mp.2013.182.
113. Lin T.Y., Lee W.C., Soo K.M., Lin H.L. Predictors of intracranial hemorrhage in patients taking anticoagulant and antiplatelet medication. Journal of Trauma 2011, 70(3):764. 10.1097/TA.0b013e318206cb18.
114. Liu R., Choi J. Age-associated decline in gamma-glutamylcysteine synthetase gene expression in rats. Free Radical Biology & Medicine 2000, 28(4):566-574.
115. Liu K.P., Wong D., Chung A.C., Kwok N., Lam M.K., Yuen C.M., et al. Effectiveness of a workplace training programme in improving social, communication and emotional skills for adults with autism and intellectual disability in Hong Kong-a pilot study. Occupational Therapy International 2013, 20(4):198-204. 10.1002/oti.1356.
116. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nature Reviews. Neuroscience 2003, 4(5):399-415. nrn1106 [pii]. 10.1038/nrn1106.
117. Lucke-Wold B.P., Turner R.C., Lucke-Wold A.N., Rosen C.L., Huber J.D. Age and the metabolic syndrome as risk factors for ischemic stroke: Improving preclinical models of ischemic stroke. The Yale Journal of Biology and Medicine 2012, 85(4):523-539.
118. Lue L.F., Rydel R., Brigham E.F., Yang L.B., Hampel H., Murphy G.M., et al. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 2001, 35(1):72-79.
119. Malaguarnera M., Vacante M., Frazzetto P.M., Motta M. The role of diabetes and aging in the determinism of hypertension and the related cerebrovascular complications. Archives of Gerontology and Geriatrics 2012, 55(2):221-225. 10.1016/j.archger.2011.08.008.
120. Manor B.D., Hu K., Peng C.K., Lipsitz L.A., Novak V. Posturo-respiratory synchronization: Effects of aging and stroke. Gait & Posture 2012, 36(2):254-259. 10.1016/j.gaitpost.2012.03.002.
121. Manwani B., Liu F., Scranton V., Hammond M.D., Sansing L.H., McCullough L.D. Differential effects of aging and sex on stroke induced inflammation across the lifespan. Experimental Neurology 2013, 249:120-131. 10.1016/j.expneurol.2013.08.011.
122. Manwani B., Liu F., Xu Y., Persky R., Li J., McCullough L.D. Functional recovery in aging mice after experimental stroke. Brain, Behavior, and Immunity 2011, 25(8):1689-1700. 10.1016/j.bbi.2011.06.015.
123. Martin-Calvo N., Martinez-Gonzalez M.A., Bes-Rastrollo M., Gea A., Ochoa M.C., Marti A., et al. Sugar-sweetened carbonated beverage consumption and childhood/adolescent obesity: A case-control study. Public Health Nutrition 2014, 1-9. 10.1017/S136898001300356X.
124. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430(7000):631-639. nature02621 [pii]. 10.1038/nature02621.
125. Mattson M.P., Magnus T. Ageing and neuronal vulnerability. Nature Reviews. Neuroscience 2006, 7(4):278-294. nrn1886 [pii]. 10.1038/nrn1886.
126. McEwen B.J. The influence of diet and nutrients on platelet function. Seminars in Thrombosis and Hemostasis 2014, 10.1055/s-0034-1365839.
127. McMillian M.K., Thai L., Hong J.S., O'Callaghan J.P., Pennypacker K.R. Brain injury in a dish: A model for reactive gliosis. Trends in Neurosciences 1994, 17(4):138-142.
128. Miller K.R., Streit W.J. The effects of aging, injury and disease on microglial function: A case for cellular senescence. Neuron Glia Biology 2007, 3(3):245-253. 10.1017/S1740925X08000136.
129. Mooradian A.D., Haas M.J., Chehade J.M. Age-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1). Mechanisms of Ageing and Development 2003, 124(2):143-146.
130. Moore D.J., West A.B., Dawson V.L., Dawson T.M. Molecular pathophysiology of Parkinson's disease. Annual Review of Neuroscience 2005, 28:57-87. 10.1146/annurev.neuro.28.061604.135718.
131. Morimoto R.I. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes & Development 2008, 22(11):1427-1438. 10.1101/gad.1657108.
132. Morley J.E. Treatment of hypertension in older persons: What is the evidence?. Drugs & Aging 2014, 31(5):331-337. 10.1007/s40266-014-0171-7.
133. Munshi A., Sharma V., Kaul S., Rajeshwar K., Babu M.S., Shafi G., et al. Association of the -344C/T aldosterone synthase (CYP11B2) gene variant with hypertension and stroke. Journal of the Neurological Sciences 2010, 296(1-2):34-38. 10.1016/j.jns.2010.06.013.
134. Murakami Y., Huxley R.R., Lam T.H., Tsukinoki R., Fang X., Kim H.C., et al. Diabetes, body mass index and the excess risk of coronary heart disease, ischemic and hemorrhagic stroke in the Asia pacific cohort studies collaboration. Preventive Medicine 2012, 54(1):38-41. 10.1016/j.ypmed.2011.10.010.
135. Naidoo N. ER and aging-protein folding and the ER stress response. Ageing Research Reviews 2009, 8(3):150-159. S1568-1637(09)00017-8 [pii]. 10.1016/j.arr.2009.03.001.
136. Napoli I., Neumann H. Microglial clearance function in health and disease. Neuroscience 2009, 158(3):1030-1038. 10.1016/j.neuroscience.2008.06.046.
137. Nguyen M.T., Pham I., Chemla D., Valensi P., Cosson E. Decreased stroke volume-brachial pulse pressure ratio in patients with type 2 diabetes over 50 years: The role of peripheral neuropathy. Nutrition, Metabolism, and Cardiovascular Diseases 2013, 23(11):1093-1100. 10.1016/j.numecd.2013.01.008.
138. Ning R., Chopp M., Yan T., Zacharek A., Zhang C., Roberts C., et al. Tissue plasminogen activator treatment of stroke in type-1 diabetes rats. Neuroscience 2012, 222:326-332. 10.1016/j.neuroscience.2012.07.018.
139. Ning R., Chopp M., Zacharek A., Yan T., Zhang C., Roberts C., et al. Neamine induces neuroprotection after acute ischemic stroke in type one diabetic rats. Neuroscience 2014, 257:76-85. 10.1016/j.neuroscience.2013.10.071.
140. Niranjan R. The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: Focus on astrocytes. Molecular Neurobiology 2013, 10.1007/s12035-013-8483-x.
141. Njie E.G., Boelen E., Stassen F.R., Steinbusch H.W., Borchelt D.R., Streit W.J. Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiology of Aging 2012, 33(1):195.e1-195.e12. 10.1016/j.neurobiolaging.2010.05.008.
142. O'Callaghan J.P., Sriram K. Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opinion on Drug Safety 2005, 4(3):433-442. 10.1517/14740338.4.3.433.
143. Ohsawa K., Kohsaka S. Dynamic motility of microglia: Purinergic modulation of microglial movement in the normal and pathological brain. Glia 2011, 59(12):1793-1799. 10.1002/glia.21238.
144. Orlandi A., Bochaton-Piallat M.L., Gabbiani G., Spagnoli L.G. Aging, smooth muscle cells and vascular pathobiology: Implications for atherosclerosis. Atherosclerosis 2006, 188(2):221-230. 10.1016/j.atherosclerosis.2006.01.018.
145. Ozcan L., Tabas I. Role of endoplasmic reticulum stress in metabolic disease and other disorders. Annual Review of Medicine 2012, 63:317-328. 10.1146/annurev-med-043010-144749.
146. Papadopoulos M.C., Koumenis I.L., Yuan T.Y., Giffard R.G. Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses. Neuroscience 1998, 82(3):915-925.
147. Patel J.R., Brewer G.J. Age-related changes in neuronal glucose uptake in response to glutamate and beta-amyloid. Journal of Neuroscience Research 2003, 72(4):527-536. 10.1002/jnr.10602.
148. Penninger J.M., Irie-Sasaki J., Sasaki T., Oliveira-dos-Santos A.J. CD45: New jobs for an old acquaintance. Nature Immunology 2001, 2(5):389-396. 10.1038/87687.
149. Perego C., Fumagalli S., De Simoni M.G. Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. Journal of Neuroinflammation 2011, 8:174. 10.1186/1742-2094-8-174.
150. Piccolo R.S., Yang M., Bliwise D.L., Yaggi H.K., Araujo A.B. Racial and socioeconomic disparities in sleep and chronic disease: Results of a longitudinal investigation. Ethnicity & Disease 2013, 23(4):499-507.
151. Pontiroli A.E., Alberto M., Paganelli M., Saibene A., Busetto L. Metabolic syndrome, hypertension, and diabetes mellitus after gastric banding: The role of aging and of duration of obesity. Surgery for Obesity and Related Diseases 2013, 9(6):894-900. 10.1016/j.soard.2013.04.001.
152. Popa-Wagner A., Carmichael S.T., Kokaia Z., Kessler C., Walker L.C. The response of the aged brain to stroke: too much, too soon?. Current Neurovascular Research 2007, 4(3):216-227.
153. Popa-Wagner A., Pirici D., Petcu E.B., Mogoanta L., Buga A.M., Rosen C.L., et al. Pathophysiology of the vascular wall and its relevance for cerebrovascular disorders in aged rodents. Current Neurovascular Research 2010, 7(3):251-267.
154. Poteet E., Winters A., Yan L.J., Shufelt K., Green K.N., Simpkins J.W., et al. Neuroprotective actions of methylene blue and its derivatives. PLoS One 2012, 7(10):e48279. 10.1371/journal.pone.0048279.
155. Purkayastha S., Zhang H., Zhang G., Ahmed Z., Wang Y., Cai D. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(7):2939-2944. 1006875108 [pii]. 10.1073/pnas.1006875108.
156. Raes G., De Baetselier P., Noel W., Beschin A., Brombacher F., Hassanzadeh Gh G. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. Journal of Leukocyte Biology 2002, 71(4):597-602.
157. Raes G., Noel W., Beschin A., Brys L., de Baetselier P., Hassanzadeh G.H. FIZZ1 and Ym as tools to discriminate between differentially activated macrophages. Developmental Immunology 2002, 9(3):151-159.
158. Ramirez J.M., Ramirez A.I., Salazar J.J., de Hoz R., Trivino A. Changes of astrocytes in retinal ageing and age-related macular degeneration. Experimental Eye Research 2001, 73(5):601-615. 10.1006/exer.2001.1061.
159. Reiner A.P., Carty C.L., Jenny N.S., Nievergelt C., Cushman M., Stearns-Kurosawa D.J., et al. PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: The Cardiovascular Health Study. Journal of Thrombosis and Haemostasis 2008, 6(10):1625-1632. 10.1111/j.1538-7836.2008.03118.x.
160. Richardson A., Holbrook N.J. Aging and the cellular response to stress: Reduction in the heat shock response 1996, Wiley-Liss, New York, NY. 1st ed.
161. Rietbrock S., Heeley E., Plumb J., van Staa T. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the congestive heart failure, hypertension, age >75, diabetes mellitus, and prior stroke or transient ischemic attack (CHADS2) risk stratification scheme. American Heart Journal 2008, 156(1):57-64. 10.1016/j.ahj.2008.03.010.
162. Rock R.B., Gekker G., Hu S., Sheng W.S., Cheeran M., Lokensgard J.R., et al. Role of microglia in central nervous system infections. Clinical Microbiology Reviews 2004, 17(4):942-964. (table of contents). 10.1128/CMR.17.4.942-964.2004.
163. Rodriguez J.J., Jones V.C., Verkhratsky A. Impaired cell proliferation in the subventricular zone in an Alzheimer's disease model. Neuroreport 2009, 20(10):907-912. 10.1097/WNR.0b013e32832be77d.
164. Rodriguez-Flores M., Garcia-Garcia E., Cano-Nigenda C.V., Cantu-Brito C. Relationship of obesity and insulin resistance with the cerebrovascular reactivity: A case control study. Cardiovascular Diabetology 2014, 13(1):2. 10.1186/1475-2840-13-2.
165. Roriz-Filho J.S., Sa-Roriz T.M., Rosset I., Camozzato A.L., Santos A.C., Chaves M.L., et al. (Pre)diabetes, brain aging, and cognition. Biochimica et Biophysica Acta 2009, 1792(5):432-443. 10.1016/j.bbadis.2008.12.003.
166. Rosen C.L., Dinapoli V.A., Nagamine T., Crocco T. Influence of age on stroke outcome following transient focal ischemia. Journal of Neurosurgery 2005, 103(4):687-694. 10.3171/jns.2005.103.4.0687.
167. Sacco R.L., Benjamin E.J., Broderick J.P., Dyken M., Easton J.D., Feinberg W.M., et al. American Heart Association Prevention Conference IV. Prevention and rehabilitation of stroke. Risk factors. Stroke 1997, 28(7):1507-1517.
168. Saito T., Shibasaki K., Kurachi M., Puentes S., Mikuni M., Ishizaki Y. Cerebral capillary endothelial cells are covered by the VEGF-expressing foot processes of astrocytes. Neuroscience Letters 2011, 497(2):116-121. 10.1016/j.neulet.2011.04.043.
169. Salminen A., Ojala J., Kaarniranta K., Haapasalo A., Hiltunen M., Soininen H. Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. European Journal of Neuroscience 2011, 34(1):3-11. 10.1111/j.1460-9568.2011.07738.x.
170. Samantha Sevilla M., Hubal M.J. Genetic modifiers of obesity and bariatric surgery outcomes. Seminars in Pediatric Surgery 2014, 23(1):43-48. 10.1053/j.sempedsurg.2013.10.017.
171. Sandhir R., Berman N.E. Age-dependent response of CCAAT/enhancer binding proteins following traumatic brain injury in mice. Neurochemistry International 2010, 56(1):188-193. S0197-0186(09)00282-4 [pii]. 10.1016/j.neuint.2009.10.002.
172. Sandhu S.K., Kaur G. Alterations in oxidative stress scavenger system in aging rat brain and lymphocytes. Biogerontology 2002, 3(3):161-173.
173. Schousboe A. Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission. Neurochemical Research 2003, 28(2):347-352.
174. Schwedt T.J. The migraine association with cardiac anomalies, cardiovascular disease, and stroke. Neurologic Clinics 2009, 27(2):513-523. 10.1016/j.ncl.2008.11.006.
175. Seimon R.V., Espinoza D., Ivers L., Gebski V., Finer N., Legler U.F., et al. Changes in body weight and blood pressure: Paradoxical outcome events in overweight and obese subjects with cardiovascular disease. International Journal of Obesity 2014, 10.1038/ijo.2014.2.
176. Shiber J.R., Fontane E., Adewale A. Stroke registry: Hemorrhagic vs ischemic strokes. American Journal of Emergency Medicine 2010, 28(3):331-333. 10.1016/j.ajem.2008.10.026.
177. Shiroto T., Romero N., Sugiyama T., Sartoretto J.L., Kalwa H., Yan Z., et al. Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium. PLoS One 2014, 9(2):e87871. 10.1371/journal.pone.0087871.
178. Sieradzan K.A., Mann D.M. The selective vulnerability of nerve cells in Huntington's disease. Neuropathology and Applied Neurobiology 2001, 27(1):1-21. nan299 [pii].
179. Sierra C., Coca A., Schiffrin E.L. Vascular mechanisms in the pathogenesis of stroke. Current Hypertension Reports 2011, 13(3):200-207. 10.1007/s11906-011-0195-x.
180. Sites C.K. Hormone replacement therapy: Cardiovascular benefits for aging women. Coronary Artery Disease 1998, 9(12):789-793.
181. Soares I., Abecasis P., Ferro J.M. Outcome of first-ever acute ischemic stroke in the elderly. Archives of Gerontology and Geriatrics 2011, 53(2):e81-e87. 10.1016/j.archger.2010.06.019.
182. Sohrabji F., Bake S., Lewis D.K. Age-related changes in brain support cells: Implications for stroke severity. Neurochemistry International 2013, 63(4):291-301. 10.1016/j.neuint.2013.06.013.
183. St Pie M., St Pie A., Wlaze R.N., Paradowski M., Banach M., Rysz J. Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: A comparative pilot study. Lipids in Health and Disease 2014, 13(1):29. 10.1186/1476-511X-13-29.
184. Stankowski J.N., Gupta R. Therapeutic targets for neuroprotection in acute ischemic stroke: Lost in translation?. Antioxidants & Redox Signaling 2011, 14(10):1841-1851. 10.1089/ars.2010.3292.
185. Suzuki T., Sakata H., Kato C., Connor J.A., Morita M. Astrocyte activation and wound healing in intact-skull mouse after focal brain injury. European Journal of Neuroscience 2012, 36(12):3653-3664. 10.1111/j.1460-9568.2012.08280.x.
186. Takechi R., Pallebage-Gamarallage M.M., Lam V., Giles C., Mamo J.C. Aging-related changes in blood-brain barrier integrity and the effect of dietary fat. Neuro-Degenerative Diseases 2013, 12(3):125-135. 10.1159/000343211.
187. Tang Z., Zhou T., Luo Y., Xie C., Huo D., Tao L., et al. Risk factors for cerebrovascular disease mortality among the elderly in Beijing: A competing risk analysis. PLoS One 2014, 9(2):e87884. 10.1371/journal.pone.0087884.
188. Taylor D.L., Jones F., Kubota E.S., Pocock J.M. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. The Journal of Neuroscience 2005, 25(11):2952-2964. 10.1523/JNEUROSCI.4456-04.2005.
189. Thurston R.C., Rewak M., Kubzansky L.D. An anxious heart: Anxiety and the onset of cardiovascular diseases. Progress in Cardiovascular Diseases 2013, 55(6):524-537. 10.1016/j.pcad.2013.03.007.
190. Toth P., Tucsek Z., Sosnowska D., Gautam T., Mitschelen M., Tarantini S., et al. Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. Journal of Cerebral Blood Flow and Metabolism 2013, 33(11):1732-1742. 10.1038/jcbfm.2013.143.
191. Trotti D., Danbolt N.C., Volterra A. Glutamate transporters are oxidant-vulnerable: A molecular link between oxidative and excitotoxic neurodegeneration?. Trends in Pharmacological Sciences 1998, 19(8):328-334.
192. Tsimikas S., Willeit P., Willeit J., Santer P., Mayr M., Xu Q., et al. Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events. Journal of the American College of Cardiology 2012, 60(21):2218-2229. 10.1016/j.jacc.2012.08.979.
193. Tucsek Z., Toth P., Sosnowska D., Gautam T., Mitschelen M., Koller A., et al. Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: Effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2013, glt177 [pii]. 10.1093/gerona/glt177.
194. Turner R.C., Dodson S.C., Rosen C.L., Huber J.D. The science of cerebral ischemia and the quest for neuroprotection: Navigating past failure to future success. Journal of Neurosurgery 2013, 118(5):1072-1085. 10.3171/2012.11.JNS12408.
195. Vaidya A., Williams J.S. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism 2012, 61(4):450-458. 10.1016/j.metabol.2011.09.007.
196. van Vliet-Ostaptchouk J.V., Nuotio M.L., Slagter S.N., Doiron D., Fischer K., Foco L., et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: A collaborative analysis of ten large cohort studies. BMC Endocrine Disorders 2014, 14(1):9. 10.1186/1472-6823-14-9.
197. Walz W. Role of astrocytes in the clearance of excess extracellular potassium. Neurochemistry International 2000, 36(4-5):291-300.
198. Wang C.Y., Kim H.H., Hiroi Y., Sawada N., Salomone S., Benjamin L.E., et al. Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR. Science Signaling 2009, 2(62):11. 10.1126/scisignal.2000143.
199. Warkentin L.M., Majumdar S.R., Johnson J.A., Agborsangaya C.B., Rueda-Clausen C., Sharma A.M., et al. Predictors of health-related quality of life in 500 severely obese patients: An assessment using three validated instruments. Obesity (Silver Spring) 2014, 10.1002/oby.20694.
200. Westergaard N., Sonnewald U., Schousboe A. Release of alpha-ketoglutarate, malate and succinate from cultured astrocytes: Possible role in amino acid neurotransmitter homeostasis. Neuroscience Letters 1994, 176(1):105-109.
201. Wissing K.M., Pipeleers L. Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: Prevention and treatment. Transplantation Reviews (Orlando, Fla.) 2013, 10.1016/j.trre.2013.12.004.
202. Wu Y., Zhang A.Q., Yew D.T. Age related changes of various markers of astrocytes in senescence-accelerated mice hippocampus. Neurochemistry International 2005, 46(7):565-574. 10.1016/j.neuint.2005.01.002.
203. Yamashiro K., Tanaka R., Tanaka Y., Miyamoto N., Shimada Y., Ueno Y., et al. Visceral fat accumulation is associated with cerebral small vessel disease. European Journal of Neurology 2014, 10.1111/ene.12374.
204. Yanez N.D., Burke G.L., Manolio T., Gardin J.M., Polak J. Sibling history of myocardial infarction or stroke and risk of cardiovascular disease in the elderly: The cardiovascular health study. Annals of Epidemiology 2009, 19(12):858-866. CHS Collaborative Research Group. 10.1016/j.annepidem.2009.07.095.
205. Ye S.M., Johnson R.W. Increased interleukin-6 expression by microglia from brain of aged mice. Journal of Neuroimmunology 1999, 93(1-2):139-148.
206. Yeo L.L., Paliwal P., Teoh H.L., Seet R.C., Chan B.P., Wakerley B., et al. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases 2013, 22(8):e590-e596. 10.1016/j.jstrokecerebrovasdis.2013.07.024.
207. Yoshii H., Onuma T., Yamazaki T., Watada H., Matsuhisa M., Matsumoto M., et al. Effects of pioglitazone on macrovascular events in patients with type 2 diabetes mellitus at high risk of stroke: The PROFIT-J study. Journal of Atherosclerosis and Thrombosis 2014, 21:563-573.
208. Yu S., Yang S., Holsboer F., Sousa N., Almeida O.F. Glucocorticoid regulation of astrocytic fate and function. PLoS One 2011, 6(7):e22419. 10.1371/journal.pone.0022419.
209. Zehendner C.M., White R., Hedrich J., Luhmann H.J. A neurovascular blood-brain barrier in vitro model. Methods in Molecular Biology 2014, 1135:403-413. 10.1007/978-1-4939-0320-7_33.
210. Zhou T., He Q., Tong Y., Zhan R., Xu F., Fan D., et al. Phospholipid transfer protein (PLTP) deficiency impaired blood-brain barrier integrity by increasing cerebrovascular oxidative stress. Biochemical and Biophysical Research Communications 2014, 445(2):352-356. 10.1016/j.bbrc.2014.01.194.
211. Zhu C., Joyce N.C. Proliferative response of corneal endothelial cells from young and older donors. Investigative Ophthalmology & Visual Science 2004, 45(6):1743-1751.